Stephens Consulting’s Elevance Health ELV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $65.3K | Buy |
168
+4
| +2% | +$1.56K | 0.02% | 172 |
|
|
2025
Q1 | $71.3K | Hold |
164
| – | – | 0.02% | 158 |
|
|
2024
Q4 | $60.5K | Hold |
164
| – | – | 0.02% | 174 |
|
|
2024
Q3 | $85.3K | Hold |
164
| – | – | 0.02% | 140 |
|
|
2024
Q2 | $88.9K | Hold |
164
| – | – | 0.03% | 138 |
|
|
2024
Q1 | $85K | Hold |
164
| – | – | 0.03% | 132 |
|
|
2023
Q4 | $77.3K | Hold |
164
| – | – | 0.03% | 136 |
|
|
2023
Q3 | $71.4K | Hold |
164
| – | – | 0.03% | 138 |
|
|
2023
Q2 | $72.9K | Hold |
164
| – | – | 0.03% | 131 |
|
|
2023
Q1 | $75.4K | Hold |
164
| – | – | 0.05% | 133 |
|
|
2022
Q4 | $84.1K | Hold |
164
| – | – | 0.06% | 123 |
|
|
2022
Q3 | $74.5K | Hold |
164
| – | – | 0.07% | 130 |
|
|
2022
Q2 | $79.1K | Hold |
164
| – | – | 0.06% | 126 |
|
|
2022
Q1 | $80.6K | Hold |
164
| – | – | 0.07% | 145 |
|
|
2021
Q4 | $76K | Buy |
+164
| New | +$76K | 0.06% | 158 |
|